<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03700086</url>
  </required_header>
  <id_info>
    <org_study_id>PICO (1215CESC)</org_study_id>
    <nct_id>NCT03700086</nct_id>
  </id_info>
  <brief_title>Efficacy of NPWT in Reducing the Incidence of Wound Infection After Pancreatic Surgery</brief_title>
  <official_title>Efficacy of a Disposable Negative Wound Pressure Device in Reducing the Incidence of Non-organ Space Surgical Site Infection After Clean-contaminated Pancreatic Resections: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera Universitaria Integrata Verona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Smith &amp; Nephew Wound Management Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Azienda Ospedaliera Universitaria Integrata Verona</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A disposable negative wound pressure device will be compared to standard sterile wound
      dressing in reducing the rate of wound infection after clean-contaminated surgical procedures
      on biliary tract and pancreas in patients at high risk for wound infection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The use of specific protocols for antisepsis, sterilization and infections' prophylaxis is
      widely diffused, but, however, surgical site infection rate is still high. Wound infection is
      often considered as a minor morbidity if compared with other complications, but it is able to
      considerably increase the length of hospital stay, health care and assistance related costs
      affecting patients' quality of life. The Center for Disease Control and Prevention (CDC) has
      published specific guidelines for surgical site infection (SSI) prevention that includes
      hairs removal, intravenous antibiotics on the basis of the type of procedure planned for that
      patient, skin antisepsis, surgical team antisepsis, sterility, blood glucose levels control,
      body temperature control and optimal perfusion of all tissues. At the end of the surgical
      procedure, surgical incision is covered with a sterile dressing that usually is changed after
      24/48 hours. Clean-contaminated procedures like pancreaticoduodenectomy (PD), total
      pancreatectomy (TP) and palliative procedures like gastric by-pass and hepaticojejunostomy
      GEA/HJ) are considered at high complexity with a high incidence of SSI, especially dealing
      with patients at high surgical risk. Since from the introduction of negative wound pressure
      therapy in 1997, these devices have been used only for the treatment of acute and chronic
      wounds with loss of tissue, but recently have also been proposed in the setting of SSI
      prevention. Negative wound pressure systems have higher costs, the use in the outpatients
      setting may be complex consequently the use in the setting of SSI prevention could not result
      cost-effective.

      The rationale for the use of negative pressure therapy in the prevention of SSI relies in the
      complete clearance of dead-space under the incision, fluids and blood removal with consequent
      reduction of fluids infections, edema reduction, blood flow improvement and tissue
      oxygenation. Similar results can be obtained through a less expensive, disposable,
      canisterless, negative pressure wound therapy device (Pico®, Smith&amp;Nephew). This system is
      cheaper, is portable, and can produce a continue vacuum with a nominal pressure of -80mmHg
      being able to achieve a rapid discharge at home with less frequent medications, improved
      comfort and aesthetic result.

      The following study is designed to assess the effect of a disposable, canisterless, negative
      pressure wound therapy device in the reduction of SSI in high risk patients if compared with
      a sterile standard dressing after major pancreatic procedures.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 25, 2018</start_date>
  <completion_date type="Actual">October 10, 2019</completion_date>
  <primary_completion_date type="Actual">October 10, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>1:1 randomized controlled trial</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Surgical Site Infection (non-organ space)</measure>
    <time_frame>30 days from index surgery</time_frame>
    <description>Superficial + deep surgical site infection as defined by CDC</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of discontinuation of negative wound pressure therapy</measure>
    <time_frame>7 days from index surgery</time_frame>
    <description>Discontinuation of therapy due to patient choice</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of seromas</measure>
    <time_frame>30 days from index surgery</time_frame>
    <description>As defined by CDC</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of hematomas</measure>
    <time_frame>30 days from index surgery</time_frame>
    <description>As defined by CDC</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of major morbidities</measure>
    <time_frame>30 days from index surgery</time_frame>
    <description>Incidence of pancreatic fistula, hemorrhage, delayed gastric emptying, Clavien -Dindo morbidity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stony Brook Scar Evaluation Scale Score</measure>
    <time_frame>30 days after index surgery</time_frame>
    <description>The Stony Brook Evaluation Scale evaluate the aesthetic result of an incision. Score ranges from 0 (worst aesthetic result) to 5 (best aesthetic result)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Surgical Site Infection</condition>
  <arm_group>
    <arm_group_label>Negative wound pressure device (PICO)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The disposable negative wound pressure device (PICO) will be used to cover the midline incision. The dressing is changed on POD3 and removed on POD7. Data are collected on POD3, POD7 and POD30.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard sterile dressing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The OPsite post-op visible standard sterile dressing will be used to cover the midline incision. Dressing is changed q48h. Data are collected on POD3, POD7 and POD30.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Disposable negative wound pressure device (PICO)</intervention_name>
    <description>Application of a disposable negative wound pressure device for surgical site infection prevention.</description>
    <arm_group_label>Negative wound pressure device (PICO)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>OPsite post-op visible standard sterile dressing</intervention_name>
    <description>Application of a standard sterile wound dressing.</description>
    <arm_group_label>Standard sterile dressing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18

          -  Informed consent

          -  HPB clean-contaminated procedures (PD, TP and GEA/HJ)

          -  Median laparotomy

          -  Compliance with a follow-up protocol

          -  High risk for SSI (at least one of the following):

               -  Body Mass Index &gt; 30kg/m2

               -  Diabetes mellitus type I or II

               -  Use of steroids

               -  Neoadjuvant therapy

               -  ASA ≥ 3

               -  Charlson Comorbidity Index 1

               -  Time of surgery &gt; 360'

               -  Estimated blood loss &gt; 1L

        Exclusion Criteria:

          -  Previous open surgery of the abdomen

          -  Unable to give informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luca Landoni, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AOVR Veneto</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ospedale Policlinico GB Rossi</name>
      <address>
        <city>Verona</city>
        <zip>37134</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <results_reference>
    <citation>Fiorio M, Marvaso A, Viganò F, Marchetti F. Incidence of surgical site infections in general surgery in Italy. Infection. 2006 Dec;34(6):310-4.</citation>
    <PMID>17180584</PMID>
  </results_reference>
  <results_reference>
    <citation>Allegranzi B, Bagheri Nejad S, Combescure C, Graafmans W, Attar H, Donaldson L, Pittet D. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet. 2011 Jan 15;377(9761):228-41. doi: 10.1016/S0140-6736(10)61458-4. Epub 2010 Dec 9. Review.</citation>
    <PMID>21146207</PMID>
  </results_reference>
  <results_reference>
    <citation>Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999 Apr;20(4):250-78; quiz 279-80.</citation>
    <PMID>10219875</PMID>
  </results_reference>
  <results_reference>
    <citation>Ceppa EP, Pitt HA, House MG, Kilbane EM, Nakeeb A, Schmidt CM, Zyromski NJ, Lillemoe KD. Reducing surgical site infections in hepatopancreatobiliary surgery. HPB (Oxford). 2013 May;15(5):384-91. doi: 10.1111/j.1477-2574.2012.00604.x. Epub 2012 Nov 5.</citation>
    <PMID>23557410</PMID>
  </results_reference>
  <results_reference>
    <citation>Argenta LC, Morykwas MJ. Vacuum-assisted closure: a new method for wound control and treatment: clinical experience. Ann Plast Surg. 1997 Jun;38(6):563-76; discussion 577.</citation>
    <PMID>9188971</PMID>
  </results_reference>
  <results_reference>
    <citation>Morykwas MJ, Argenta LC, Shelton-Brown EI, McGuirt W. Vacuum-assisted closure: a new method for wound control and treatment: animal studies and basic foundation. Ann Plast Surg. 1997 Jun;38(6):553-62.</citation>
    <PMID>9188970</PMID>
  </results_reference>
  <results_reference>
    <citation>Masden D, Goldstein J, Endara M, Xu K, Steinberg J, Attinger C. Negative pressure wound therapy for at-risk surgical closures in patients with multiple comorbidities: a prospective randomized controlled study. Ann Surg. 2012 Jun;255(6):1043-7. doi: 10.1097/SLA.0b013e3182501bae.</citation>
    <PMID>22549748</PMID>
  </results_reference>
  <results_reference>
    <citation>Vargo D. Negative pressure wound therapy in the prevention of wound infection in high risk abdominal wound closures. Am J Surg. 2012 Dec;204(6):1021-3; discussion 1023-4. doi: 10.1016/j.amjsurg.2012.10.004.</citation>
    <PMID>23231938</PMID>
  </results_reference>
  <results_reference>
    <citation>Blackham AU, Farrah JP, McCoy TP, Schmidt BS, Shen P. Prevention of surgical site infections in high-risk patients with laparotomy incisions using negative-pressure therapy. Am J Surg. 2013 Jun;205(6):647-54. doi: 10.1016/j.amjsurg.2012.06.007. Epub 2013 Jan 30.</citation>
    <PMID>23375758</PMID>
  </results_reference>
  <results_reference>
    <citation>Bonds AM, Novick TK, Dietert JB, Araghizadeh FY, Olson CH. Incisional negative pressure wound therapy significantly reduces surgical site infection in open colorectal surgery. Dis Colon Rectum. 2013 Dec;56(12):1403-8. doi: 10.1097/DCR.0b013e3182a39959.</citation>
    <PMID>24201395</PMID>
  </results_reference>
  <results_reference>
    <citation>Grauhan O, Navasardyan A, Hofmann M, Müller P, Stein J, Hetzer R. Prevention of poststernotomy wound infections in obese patients by negative pressure wound therapy. J Thorac Cardiovasc Surg. 2013 May;145(5):1387-92. doi: 10.1016/j.jtcvs.2012.09.040. Epub 2012 Oct 27.</citation>
    <PMID>23111014</PMID>
  </results_reference>
  <results_reference>
    <citation>Webster J, Scuffham P, Sherriff KL, Stankiewicz M, Chaboyer WP. Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention. Cochrane Database Syst Rev. 2012 Apr 18;(4):CD009261. doi: 10.1002/14651858.CD009261.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;(10):CD009261.</citation>
    <PMID>22513974</PMID>
  </results_reference>
  <results_reference>
    <citation>Malmsjö M, Huddleston E, Martin R. Biological effects of a disposable, canisterless negative pressure wound therapy system. Eplasty. 2014 Apr 2;14:e15. eCollection 2014.</citation>
    <PMID>24741386</PMID>
  </results_reference>
  <results_reference>
    <citation>Fong ZV, McMillan MT, Marchegiani G, Sahora K, Malleo G, De Pastena M, Loehrer AP, Lee GC, Ferrone CR, Chang DC, Hutter MM, Drebin JA, Bassi C, Lillemoe KD, Vollmer CM, Fernández-Del Castillo C. Discordance Between Perioperative Antibiotic Prophylaxis and Wound Infection Cultures in Patients Undergoing Pancreaticoduodenectomy. JAMA Surg. 2016 May 1;151(5):432-9. doi: 10.1001/jamasurg.2015.4510.</citation>
    <PMID>26720272</PMID>
  </results_reference>
  <results_reference>
    <citation>Payne C, Edwards D. Application of the Single Use Negative Pressure Wound Therapy Device (PICO) on a Heterogeneous Group of Surgical and Traumatic Wounds. Eplasty. 2014 Apr 28;14:e20. eCollection 2014.</citation>
    <PMID>24917894</PMID>
  </results_reference>
  <results_reference>
    <citation>Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Am J Infect Control. 1992 Oct;20(5):271-4.</citation>
    <PMID>1332552</PMID>
  </results_reference>
  <results_reference>
    <citation>Wente MN, Veit JA, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR, Neoptolemos JP, Padbury RT, Sarr MG, Yeo CJ, Büchler MW. Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery. 2007 Jul;142(1):20-5. Review.</citation>
    <PMID>17629996</PMID>
  </results_reference>
  <results_reference>
    <citation>Wente MN, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR, Neoptolemos JP, Padbury RT, Sarr MG, Traverso LW, Yeo CJ, Büchler MW. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2007 Nov;142(5):761-8.</citation>
    <PMID>17981197</PMID>
  </results_reference>
  <results_reference>
    <citation>Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, Neoptolemos J, Sarr M, Traverso W, Buchler M; International Study Group on Pancreatic Fistula Definition. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005 Jul;138(1):8-13. Review.</citation>
    <PMID>16003309</PMID>
  </results_reference>
  <results_reference>
    <citation>Singer AJ, Arora B, Dagum A, Valentine S, Hollander JE. Development and validation of a novel scar evaluation scale. Plast Reconstr Surg. 2007 Dec;120(7):1892-7.</citation>
    <PMID>18090752</PMID>
  </results_reference>
  <results_reference>
    <citation>Pellino G, Sciaudone G, Candilio G, Campitiello F, Selvaggi F, Canonico S. Effects of a new pocket device for negative pressure wound therapy on surgical wounds of patients affected with Crohn's disease: a pilot trial. Surg Innov. 2014 Apr;21(2):204-12. doi: 10.1177/1553350613496906. Epub 2013 Jul 24.</citation>
    <PMID>23883481</PMID>
  </results_reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>May 15, 2018</study_first_submitted>
  <study_first_submitted_qc>October 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2018</study_first_posted>
  <last_update_submitted>May 6, 2020</last_update_submitted>
  <last_update_submitted_qc>May 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>negative pressure wound therapy</keyword>
  <keyword>wound infection</keyword>
  <keyword>pancreaticoduodenectomy</keyword>
  <keyword>total pancreatectomy</keyword>
  <keyword>surgical palliation of pancreatic cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Surgical Wound Infection</mesh_term>
    <mesh_term>Wound Infection</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

